ClinicalTrials.gov
public full text
Public Domain
Study of ORIC-101 in Healthy Adult Subjects
ORIC-GR-17001 is an open-label, single center, non-randomized, single ascending dose study in healthy male subjects and healthy female subjects of non-child bearing potential. In this study, ORIC-101 will be administered as single-ascending oral doses. The primary objective is to characterize the safety and tolerability of oral ORIC-101.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders#904342
- Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine#832102
- Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219#1032319
- Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)#1161758
- ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults#869829
Record · ID 1094223
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive